Lalli, Jaspreet – Trademark Portfolio

Entity Type: 01

Lalli, Jaspreet holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CALIFORNIA PET PHARMACY and HEALTHY PETS ARE HAPPY PETS!. The owner is based in Hayward, CA.

3157 Corporate Place

Hayward, CA 94545

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Lalli, Jaspreet's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Lalli, Jaspreet have?

Lalli, Jaspreet has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Lalli, Jaspreet file in?

Lalli, Jaspreet files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What are Lalli, Jaspreet's most well-known trademarks?

Lalli, Jaspreet's registered trademark portfolio includes well-known marks such as CALIFORNIA PET PHARMACY and HEALTHY PETS ARE HAPPY PETS!. These are among 2 currently registered trademarks in the portfolio.

What is Lalli, Jaspreet's trademark registration success rate?

Lalli, Jaspreet has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.